Mechanisms of liver disease in patients infected with HIV
- PMID: 29119002
- PMCID: PMC5663263
- DOI: 10.1136/bmjgast-2017-000166
Mechanisms of liver disease in patients infected with HIV
Abstract
Objective: To describe the various mechanisms of liver disease in patients with HIV infection, and to link these mechanisms to disease states which may utilise them.
Background: Non-AIDS causes of morbidity and mortality are becoming increasingly common in patients chronically infected with HIV. In particular, liver-related diseases have risen to become one of the leading causes of non-AIDS-related death. A thorough understanding of the mechanisms driving the development of liver disease in these patients is essential when evaluating and caring for these patients.
Methods: The literature regarding mechanisms of liver disease by which different disease entities may cause hepatic injury and fibrosis was reviewed and synthesised.
Results: A number of discrete mechanisms of injury were identified, to include: oxidative stress, mitochondrial injury, lipotoxicity, immune-mediated injury, cytotoxicity, toxic metabolite accumulation, gut microbial translocation, systemic inflammation, senescence and nodular regenerative hyperplasia. Disease states may use any number of these mechanisms to exert their effect on the liver.
Conclusions: The mechanisms by which liver injury may occur in patients with HIV infection are numerous. Most disease states use multiple mechanisms to cause hepatic injury and fibrosis.
Keywords: HIV; cirrhosis; hepatitis; liver fibrosis.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Palella FJ, Delaney KM, Moorman AC, et al. . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med 1998;338:853–60. doi:10.1056/NEJM199803263381301 - DOI - PubMed
-
- Konopnicki D, Mocroft A, de Wit S, et al. . Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005;19:593–601. doi:10.1097/01.aids.0000163936.99401.fe - DOI - PubMed
-
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558–67. doi:10.1016/S1473-3099(05)70216-4 - DOI - PubMed
-
- Lemoine M, Serfaty L, Capeau J. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients. Curr Opin Infect Dis 2012;25:10–16. doi:10.1097/QCO.0b013e32834ef599 - DOI - PubMed
-
- Palella FJ, Baker RK, Moorman AC, et al. . Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27–34. doi:10.1097/01.qai.0000233310.90484.16 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical